… Medicines Agency -- the European Union's counterpart to the U.S. Food and Drug Administration (FDA) -- last week … Diane Stephenson, PhD, executive director of the CPP. Overcoming Trial Challenges Studies of new Parkinson's … are more likely to have symptom worsening and be able to show a benefit if the therapy is successful. The MJFF-led …

… basket raffle. Eric Aquino, a 41-year-old who lives in Easton, Pennsylvania, doesn’t take life for granted. He’s an … the most challenging symptoms he faces, he also points out how difficult it can be to manage anxiety , a common non-motor symptom of the disease. Eric is proactive …

… are abnormal and involuntary movements that relate in part to underlying Parkinson’s disease itself and to drugs used … to measure dyskinesia characteristics over time allows for comparability of treatment outcomes, helps the … and adaptation of several pre-existing scales that together assess the key components of dyskinesias. The UDysRS …

… NEWYORK, NY — The Michael J. Fox Foundation has committed up to $3.8 million for the development of a gene silencing … are needed. This LEAPS grant is characteristic of how The Michael J. Fox Foundation goes about its work — …